Target intelligence / Profile preview

Sterile alpha motif domain-containing protein 7 (SAMD7)

Target
SAMD7
Molecular classification
Transcriptional corepressor, Chromatin-associated protein, Polycomb repressive complex component, SAM domain-containing protein, Other (not an enzyme, receptor, transporter, or ion channel)
01

Overview

Sterile alpha motif domain-containing protein 7 (SAMD7) is a nuclear protein essential for the epigenetic regulation of gene expression in retinal photoreceptor cells. It acts as a transcriptional corepressor by interacting with transcription factors such as Cone-Rod Homeobox (CRX) and rod-specific Nr2e3, recruiting the Polycomb repressive complex 1 (PRC1) to mediate gene silencing through chromatin modification. SAMD7 specifically silences nonrod gene expression in rod photoreceptor cells by promoting H3K27me3 deposition and chromatin compaction, thus defining rod cell identity. Mutations in SAMD7 cause autosomal-recessive macular dystrophy, highlighting its crucial role in human retinal function[1][2][3][5][6]. SAMD7 is primarily expressed in the retina, localized to the nuclei of rods and cones, and the inner nuclear layer of the retina[2][3][5]. There is currently no evidence that SAMD7 is a direct drug target or that drugs interact with this protein.

Other names
SAMD7Sterile alpha motif domain containing 7SAM domain-containing protein 7DKFZp686E1583MDCD
02

Mechanism of action

No drugs act on SAMD7, so mechanisms of drug action targeting it are unavailable.

03

Biological functions

Epigenetic gene silencingTranscriptional repressionChromatin compactionRegulation of photoreceptor cell identity and differentiation (especially rod cells)Silencing nonrod gene expression in photoreceptor cells
04

Disease associations

Inherited retinal diseases (e.g., autosomal-recessive macular dystrophy)Macular dystrophy (disorder of the retina leading to central vision impairment)
05

Safety considerations

No therapeutic context; hence, no known safety concerns or therapeutic challenges related to direct targeting
06

Biomarkers

No validated biomarkers for patient selection or efficacy monitoring reported for SAMD7 gene or protein in the context of therapy

Beyond the preview

Go deeper on Sterile alpha motif domain-containing protein 7 (SAMD7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sterile alpha motif domain-containing protein 7 (SAMD7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call